Skip to main content

ADVERTISEMENT

Yoshio Kobayashi, MD

08/30/2012
ABSTRACT: Deployment of a polytetrafluoroethylene-covered stent is a useful option to seal coronary perforation. However, the high profile and low flexibility compromise its deliverability. To facilitate stent delivery, deep-vessel intubation...
ABSTRACT: Deployment of a polytetrafluoroethylene-covered stent is a useful option to seal coronary perforation. However, the high profile and low flexibility compromise its deliverability. To facilitate stent delivery, deep-vessel intubation...
ABSTRACT: Deployment of a...
08/30/2012
Journal of Invasive Cardiology
08/01/2008
Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...
Lower restenosis rates were shown in selected lesions with the first-generation Palmaz-Schatz stent when compared to conventional balloon angioplasty.1 However, because the Palmaz-Schatz stent and its delivery system were rigid, stent...
Lower restenosis rates were...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Recently, lower restenosis rates have been demonstrated by directional coronary atherectomy (DCA) followed by stenting compared to stenting alone.1 This strategy may be suitable for ostial lesions, which are associated with a high risk of...
Recently, lower restenosis rates have been demonstrated by directional coronary atherectomy (DCA) followed by stenting compared to stenting alone.1 This strategy may be suitable for ostial lesions, which are associated with a high risk of...
Recently, lower restenosis rates...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Intracoronary stents reduce restenosis compared with conventional balloon angioplasty.1,2 However, in-stent restenosis remains an important clinical problem.3,4 Recently, randomized trials have demonstrated that intracoronary vascular...
Intracoronary stents reduce restenosis compared with conventional balloon angioplasty.1,2 However, in-stent restenosis remains an important clinical problem.3,4 Recently, randomized trials have demonstrated that intracoronary vascular...
Intracoronary stents reduce...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Poor long-term patency rates have been documented for saphenous vein grafts; only 50–60% of saphenous vein grafts are patent 10 years post-operation.1 On the other hand, excellent long-term patency of the left internal mammary artery for...
Poor long-term patency rates have been documented for saphenous vein grafts; only 50–60% of saphenous vein grafts are patent 10 years post-operation.1 On the other hand, excellent long-term patency of the left internal mammary artery for...
Poor long-term patency rates...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Since randomized studies showed a lower restenosis rate in focal coronary artery lesions with coronary stenting compared to conventional balloon angioplasty,1 indications for stenting expanded to complex lesions such as bifurcation and...
Since randomized studies showed a lower restenosis rate in focal coronary artery lesions with coronary stenting compared to conventional balloon angioplasty,1 indications for stenting expanded to complex lesions such as bifurcation and...
Since randomized studies showed...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Since the coronary stent was introduced, the complication rate after percutaneous coronary intervention (PCI) has been reduced.1 However, lesions with large thrombus burden are still associated with high morbidity and mortality rates after...
Since the coronary stent was introduced, the complication rate after percutaneous coronary intervention (PCI) has been reduced.1 However, lesions with large thrombus burden are still associated with high morbidity and mortality rates after...
Since the coronary stent was...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
A sirolimus-eluting stent (SES) consists of 3 components: 1) metallic stent; 2) sirolimus as an antiproliferative agent to inhibit neointimal formation; and 3) a polymer coating used as a drug-carrier vehicle (Figure 1).1 Polymer also plays...
A sirolimus-eluting stent (SES) consists of 3 components: 1) metallic stent; 2) sirolimus as an antiproliferative agent to inhibit neointimal formation; and 3) a polymer coating used as a drug-carrier vehicle (Figure 1).1 Polymer also plays...
A sirolimus-eluting stent (SES)...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
01/30/2012
Abstract: Objectives. The present study evaluated the mechanism of edge restenosis after sirolimus-eluting stent (SES) implantation using serial (post-intervention and follow-up) intravascular ultrasound (IVUS) analysis. Background. There is...
Abstract: Objectives. The present study evaluated the mechanism of edge restenosis after sirolimus-eluting stent (SES) implantation using serial (post-intervention and follow-up) intravascular ultrasound (IVUS) analysis. Background. There is...
Abstract: Objectives. The...
01/30/2012
Journal of Invasive Cardiology